Αποτελέσματα Αναζήτησης
26 Ιουν 2020 · Their main objective of this clinical trial was to evaluate nine total cats in a single-arm, prospective clinical trial to determine if this compound is safely tolerated in cats with pulmonary carcinoma and if the compound exerts anti-cancer effects in patients suffering from this cancer.
11 Αυγ 2023 · According to all this research, two direct KRAS G12C (OFF) inhibitors, Sotorasib and Adagrasib, earned the breakthrough designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with KRAS G12C metastatic lung cancer and have shown promising results in phase I and II clinical trials (NCT04625647, NCT04933695 ...
4 Οκτ 2021 · Medical treatment was well tolerated and appeared to palliate clinical signs in cats with metastatic pulmonary carcinoma, albeit with a modest duration and short overall survival. The role and benefit of chemotherapy/antineoplastic agents versus conventional palliative drugs in this setting remains unclear.
4 Οκτ 2021 · The aim of this study was to describe the outcome of cats affected by metastatic primary pulmonary carcinoma, treated with antineoplastic agents, anti-inflammatory drugs only or no treatment and to assess the tolerability of palliative treatment in this population.
12 Απρ 2024 · The key breakthrough, says Robert Winn, a lung cancer specialist at Virginia Commonwealth University, is the ability to better pinpoint the mutations of a patient's particular form of...
21 Φεβ 2023 · Recent trials on lung cancer patients (without a targetable oncogenic driver alteration) reveal significant and sustained responses when treated with programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) checkpoint blockade immunotherapies.
6 Απρ 2024 · Lung cancer, a multifaceted disease, demands tailored therapeutic approaches due to its diverse subtypes and stages. This comprehensive review explores the intricate landscape of lung cancer research, delving into recent breakthroughs and their implications for diagnosis, therapy, and prevention.
